{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:38:55Z","timestamp":1765039135221},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,1,7]],"date-time":"2011-01-07T00:00:00Z","timestamp":1294358400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s10014-010-0016-y","type":"journal-article","created":{"date-parts":[[2011,1,6]],"date-time":"2011-01-06T12:04:14Z","timestamp":1294315454000},"page":"107-114","source":"Crossref","is-referenced-by-count":13,"title":["High-throughput immunohistochemical profiling of primary brain tumors and non-neoplastic systemic organs with a specific antibody against the mutant isocitrate dehydrogenase 1 R132H protein"],"prefix":"10.1007","volume":"28","author":[{"given":"Hayato","family":"Ikota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumihito","family":"Nobusawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Yokoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Nakazato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,1,7]]},"reference":[{"key":"16_CR1","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","volume":"321","author":"DW Parsons","year":"2008","unstructured":"Parsons DW, Jones S, Zhang X et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807\u20131812","journal-title":"Science"},{"key":"16_CR2","doi-asserted-by":"crossref","first-page":"6002","DOI":"10.1158\/1078-0432.CCR-09-0715","volume":"15","author":"S Nobusawa","year":"2009","unstructured":"Nobusawa S, Watanabe T, Kleihues P, Ohgaki H (2009) IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas. Clin Cancer Res 15:6002\u20136007","journal-title":"Clin Cancer Res"},{"key":"16_CR3","doi-asserted-by":"crossref","unstructured":"Hartmann C, Meyer J, Balss J et al (2009) Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathol 118:469\u2013474","DOI":"10.1007\/s00401-009-0561-9"},{"key":"16_CR4","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1200\/JCO.2009.21.9832","volume":"27","author":"M Sanson","year":"2009","unstructured":"Sanson M, Marie Y, Paris S et al (2009) Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol 27:4150\u20134154","journal-title":"J Clin Oncol"},{"key":"16_CR5","doi-asserted-by":"crossref","unstructured":"Kloosterhof NK, Bralten LB, Dubbink HJ et al (2010) Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma? Lancet Oncol. doi: 10.1016\/S1470-2045(10)70053-X","DOI":"10.1016\/S1470-2045(10)70053-X"},{"key":"16_CR6","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","volume":"360","author":"H Yan","year":"2009","unstructured":"Yan H, Parsons DW, Jin G et al (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765\u2013773","journal-title":"N Engl J Med"},{"key":"16_CR7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1215\/15228517-2009-025","volume":"11","author":"K Ichimura","year":"2009","unstructured":"Ichimura K, Pearson DM, Kocialkowski S et al (2009) IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas. Neuro Oncol 11:341\u2013347","journal-title":"Neuro Oncol"},{"key":"16_CR8","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2353\/ajpath.2009.080958","volume":"174","author":"T Watanabe","year":"2009","unstructured":"Watanabe T, Nobusawa S, Kleihues P, Ohgaki H (2009) IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol 174:1149\u20131153","journal-title":"Am J Pathol"},{"key":"16_CR9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00401-009-0595-z","volume":"118","author":"D Capper","year":"2009","unstructured":"Capper D, Zentgraf H, Balss J et al (2009) Monoclonal antibody specific for IDH1 R132H mutation. Acta Neuropathol 118:599\u2013601","journal-title":"Acta Neuropathol"},{"key":"16_CR10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1750-3639.2009.00352.x","volume":"20","author":"D Capper","year":"2010","unstructured":"Capper D, Weissert S, Balss J et al (2010) Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors. Brain Pathol 20:245\u2013254","journal-title":"Brain Pathol"},{"key":"16_CR11","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nm0798-844","volume":"4","author":"J Kononen","year":"1998","unstructured":"Kononen J, Bubendorf L, Kallioniemi A et al (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844\u2013847","journal-title":"Nat Med"},{"key":"16_CR12","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00401-006-0060-1","volume":"111","author":"H Ikota","year":"2006","unstructured":"Ikota H, Kinjo S, Yokoo H, Nakazato Y (2006) Systematic immunohistochemical profiling of 378 brain tumors with 37 antibodies using tissue microarray technology. Acta Neuropathol 111:475\u2013482","journal-title":"Acta Neuropathol"},{"key":"16_CR13","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1097\/PAS.0b013e3181e7740d","volume":"34","author":"D Capper","year":"2010","unstructured":"Capper D, Sahm F, Hartmann C et al (2010) Application of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes. Am J Surg Pathol 34:1199\u20131204","journal-title":"Am J Surg Pathol"},{"key":"16_CR14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00401-009-0632-y","volume":"119","author":"S Camelo-Piragua","year":"2010","unstructured":"Camelo-Piragua S, Jansen M, Ganguly A et al (2010) Mutant IDH1-specific immunohistochemistry distinguishes diffuse astrocytoma from astrocytosis. Acta Neuropathol 119:509\u2013511","journal-title":"Acta Neuropathol"},{"key":"16_CR15","doi-asserted-by":"crossref","unstructured":"Louis DN, Ohgaki H, Wiestler OD et al (2007) WHO classification of tumours of the central nervous system. IARC, Lyon","DOI":"10.1007\/s00401-007-0278-6"},{"key":"16_CR16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00401-008-0455-2","volume":"116","author":"J Balss","year":"2008","unstructured":"Balss J, Meyer J, Mueller W et al (2008) Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol 116:597\u2013602","journal-title":"Acta Neuropathol"},{"key":"16_CR17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/humu.20937","volume":"30","author":"FE Bleeker","year":"2009","unstructured":"Bleeker FE, Lamba S, Leenstra S et al (2009) IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. Hum Mutat 30:7\u201311","journal-title":"Hum Mutat"},{"key":"16_CR18","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/jnci\/djq187","volume":"102","author":"ZJ Reitman","year":"2010","unstructured":"Reitman ZJ, Yan H (2010) Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism. J Natl Cancer Inst 102:932\u2013941","journal-title":"J Natl Cancer Inst"},{"key":"16_CR19","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJMoa0903840","volume":"361","author":"ER Mardis","year":"2009","unstructured":"Mardis ER, Ding L, Dooling DJ et al (2009) Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 361:1058\u20131066","journal-title":"N Engl J Med"},{"key":"16_CR20","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1210\/jc.2009-2170","volume":"95","author":"J Gaal","year":"2010","unstructured":"Gaal J, Burnichon N, Korpershoek E et al (2010) Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas. J Clin Endocrinol Metab 95:1274\u20131278","journal-title":"J Clin Endocrinol Metab"},{"key":"16_CR21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/ijc.24379","volume":"125","author":"MR Kang","year":"2009","unstructured":"Kang MR, Kim MS, Oh JE et al (2009) Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers. Int J Cancer 125:353\u2013355","journal-title":"Int J Cancer"},{"key":"16_CR22","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.1133427","volume":"314","author":"T Sj\u00f6blom","year":"2006","unstructured":"Sj\u00f6blom T, Jones S, Wood LD et al (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314:268\u2013274","journal-title":"Science"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-010-0016-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10014-010-0016-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-010-0016-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:38:20Z","timestamp":1637109500000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10014-010-0016-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,7]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["16"],"URL":"https:\/\/doi.org\/10.1007\/s10014-010-0016-y","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"value":"1433-7398","type":"print"},{"value":"1861-387X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,7]]}}}